Systemic autoinflammatory diseases: Clinical state of the art - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Best Practice and Research: Clinical Rheumatology Année : 2020

Systemic autoinflammatory diseases: Clinical state of the art

Résumé

Systemic autoinflammatory diseases (SAIDs) are defined as disorders of innate immunity. They were initially defined in opposition to autoimmune diseases due to the lack of involvement of the adaptive immune system and circulating autoantibodies. The four historical monogenic diseases are familial Mediterranean fever (associated with MEFV mutations), cryopyrinopathies (NLRP3 mutations), tumor necrosis factor receptor-associated periodic syndrome (TNFRSF1A mutations), and mevalonate kinase deficiency (MVK mutations). In the last 10 years, more than 50 new monogenic SAIDs have been discovered thanks to advances in genetics. Diagnosis is largely based on personal and family history and detailed analysis of signs and symptoms associated with febrile attacks, in the setting of elevated inflammatory markers. Increasingly efficient techniques of genetic analysis can contribute to refining the diagnosis. This review is a guide for the clinician in suspecting and establishing a diagnosis of SAID.
Systemic autoinflammatory diseases (SAIDs) are defined as disorders of innate immunity. They were initially defined in opposition to autoimmune diseases due to the lack of involvement of the adaptive immune system and circulating autoantibodies. The four historical monogenic diseases are familial Mediterranean fever (associated with MEFV mutations), cryopyrinopathies (NLRP3 mutations), tumor necrosis factor receptor-associated periodic syndrome (TNFRSF1A mutations), and mevalonate kinase deficiency (MVK mutations). In the last 10 years, more than 50 new monogenic SAIDs have been discovered thanks to advances in genetics. Diagnosis is largely based on personal and family history and detailed analysis of signs and symptoms associated with febrile attacks, in the setting of elevated inflammatory markers. Increasingly efficient techniques of genetic analysis can contribute to refining the diagnosis. This review is a guide for the clinician in suspecting and establishing a diagnosis of SAID.
Fichier principal
Vignette du fichier
Georgin-Lavialle et al. - 2020 - Systemic autoinflammatory diseases Clinical state.pdf (313.92 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03162674 , version 1 (08-03-2021)

Identifiants

Citer

Sophie Georgin-Lavialle, Stéphanie Ducharme-Benard, Guillaume Sarrabay, Léa Savey, Gilles Grateau, et al.. Systemic autoinflammatory diseases: Clinical state of the art. Best Practice and Research: Clinical Rheumatology, 2020, 34 (4), pp.101529. ⟨10.1016/j.berh.2020.101529⟩. ⟨hal-03162674⟩
1080 Consultations
758 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More